Direkt zum Inhalt

Scheu, Alexander ; Schnabl, Saskia Maria ; Steiner, Daniel Patric ; Fend, Falko ; Berneburg, Mark ; Yazdi, Amir Sadegh

Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomas

Scheu, Alexander, Schnabl, Saskia Maria, Steiner, Daniel Patric, Fend, Falko, Berneburg, Mark und Yazdi, Amir Sadegh (2021) Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomas. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19 (3), S. 373-381.

Veröffentlichungsdatum dieses Volltextes: 29 Feb 2024 12:26
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.56199


Zusammenfassung

Background and Objectives: Primary cutaneous lymphomas (PCL) often strongly differ in clinical behavior and prognosis from systemic lymphomas of the same histopathologic type. The aim of the study was to investigate the distribution of PCL subtypes, the average time from disease manifestation to diagnosis, the importance of diagnostic procedures, the occurrence of secondary malignancies and the ...

Background and Objectives: Primary cutaneous lymphomas (PCL) often strongly differ in clinical behavior and prognosis from systemic lymphomas of the same histopathologic type. The aim of the study was to investigate the distribution of PCL subtypes, the average time from disease manifestation to diagnosis, the importance of diagnostic procedures, the occurrence of secondary malignancies and the different treatment modalities. Patients and Methods: Retrospective analysis of 152 patients with PCL examined at the Department of Dermatology of the University Hospital Tubingen from 2010-2012. Results: 105 patients with CTCL (69.1 %) and 47 patients with CBCL ( 30.9 %) were included. The average time from disease manifestation to diagnosis was four years. The most common diagnosed lymphoma was mycosis fungoides (MF) (47.4 %). First-line therapies here include phototherapy only (psoralen-UV-A [ PUVA], n = 48; UVB 311 nm, n = 7) or combination therapies primarily phototherapy with systemic retinoids (n = 18). Most frequent second-line therapy was interferon (INF)-alpha plus PUVA (n = 15). The outcome was favorable (45.2 % remission, 28.6 % stable disease, 22.6 % progressive disease). Malignant comorbidities were observed more frequently compared to a healthy control group. Conclusions: The diagnosis of lymphoma often takes several years. The value of staging procedures is still low and the treatment modalities for MF in earlier stages are mainly based on phototherapy.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftJDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verlag:Wiley
Ort der Veröffentlichung:HOBOKEN
Band:19
Nummer des Zeitschriftenheftes oder des Kapitels:3
Seitenbereich:S. 373-381
Datum2021
InstitutionenMedizin > Lehrstuhl für Dermatologie und Venerologie
Identifikationsnummer
WertTyp
10.1111/ddg.14400DOI
Stichwörter / Keywords;
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenJa
URN der UB Regensburgurn:nbn:de:bvb:355-epub-561998
Dokumenten-ID56199

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben